Share this

Neuroprogressive and Dementia Network Lothian team member singled out for outstanding contribution to clinical research

Neuroprogressive and Dementia Network Lothian team member singled out for outstanding contribution to clinical research

A member of the NHS Research Scotland Neuroprogressive and Dementia Network (NRS NDN) team has been honoured for her ‘professionalism and dedication to high standards’

Clinical Studies Officer for NDN Lothian, Marian Montanha has received the title of NHS Lothian Clinical Research Person of the Year 2026 for her outstanding contribution in this area.

Chief Nurse for Research and Development at NHS Lothian, Professor Juliet MacArthur said: “Marian consistently identifies innovative ways of working, enhancing communication and planning through tools such as a virtual NDN planner and strengthened national collaboration channels.

“Her contribution to the Lothian Clinical Research strategy and attainment of Clinical Research Practitioner registration reflect both her professionalism and dedication to high standards.”

Marian joined the Network two years ago after previously being involved in research focusing on early detection methods for Alzheimer’s disease.

In particular, she explored digital cognitive assessment tools and blood-based biomarker tests for Alzheimer disease.

Additionally, she worked as an assistant psychologist for Older Adults, supporting dementia diagnostic investigations and providing post diagnostic support.

Network Champion Dr Tom Russ said: “I am delighted to have the opportunity of congratulating Marian on this hugely deserved award. She is a wonderful colleague to work with and brings an attitude of innovation which is particularly valuable.

“We are proud to work alongside her, and have all benefitted from her experience and dedication to fostering a collaborative and warm working environment. 

“The Network’s Lothian team has a long-standing track record of investigating new treatments for dementia and related conditions in Phase 2b and 3 clinical trials. However, we will soon start running earlier phase trials of novel dementia treatments with the UK Dementia Trials Network and believe Marian will play a key role in supporting that as part of the wider team”.

Network Manager Jacqui Kerr added: “It’s a real pleasure to work with Marian. She truly demonstrates a strong commitment to bringing research into everyday practice and supporting healthcare innovation. I’m confident she will continue to make a very positive impact.

“As a recognised Clinical Research Practitioner, she has also evidenced her dedication to delivering safe, ethical, and high-quality trials and to bridging the gap between clinical care and scientific research.”

Marian says she is “passionate about improving patient care and advancing research into neuroprogressive disorders and dementia”.

The Network is funded by the Chief Scientist Office (CSO) to promote a culture of clinical research across Scotland in neuroprogressive diseases — such as Dementia, Parkinson Disease, Huntington Disease, Multiple Sclerosis and Motor Neurone Disease — and improve recruitment to high-quality studies from both urban and rural areas.

Publication date: 5th June 2026

Author: NHS Research Scotland